Centene gains after outlining solid growth at Investor Day

Centene Corporation's stock rose after strong financial guidance, predicting 2025 EPS of over $7.25 and reaffirming 2024 EPS guidance, signaling positive growth.

Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers

Shares of health insurers fell as lawmakers prepare legislation to break up pharmacy-benefit managers, causing significant stock declines for companies like UnitedHealth and CVS Health.

Health insurer shares fall after UnitedHealth exec murder

UnitedHealth's stock declines after CEO Brian Thompson's fatal shooting, sparking social media backlash against health insurers over coverage frustrations and demands for changes in the industry.

UnitedHealth shares drop amid executive's death and public backlash

UnitedHealth Group's shares fell 2.5% after executive Brian Thompson's murder, reflecting public anger at insurers over healthcare issues and driving scrutiny of the industry's practices.

Healthcare industry rethinks risk after murder of UnitedHealth exec

Health insurers reassess executive security after UnitedHealthcare CEO Brian Thompson's targeted murder, prompting heightened security measures due to rising tensions and threats in the healthcare industry.

Wall Street looking for CVS to show execution plan

CVS Health's new CEO, David Joyner, faces challenges in managing rising patient costs in Medicare, addressing disappointing earnings, and improving shareholder value amid significant company restructuring.

Earnings call: Centene surpasses Q3 expectations, eyes growth

Centene's Q3 2024 report showed improved EPS and solid Medicaid performance, with a positive outlook for 2025 and ongoing strategic initiatives leveraging AI for operational efficiency.

Health insurer Centene eases investor fears with better-than-expected profit

Centene exceeded Q3 earnings expectations, driven by strong commercial plans, and maintained its profit forecast, easing investor concerns amid rising Medicaid costs.

Centene stock jumps as Q3 earnings top estimates

Centene Corporation's Q3 earnings of $1.62 per share surpassed expectations, with revenue of $42.02 billion. The stock surged 10.5% following the report.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.09%